Request Demo
Last update 08 May 2026
Yangzhou Sanyao Pharmaceutical Co. Ltd.
Last update 08 May 2026
Overview
Tags
Respiratory Diseases
Infectious Diseases
Urogenital Diseases
Small molecule drug
Herbal medicine
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20261422
评价利多卡因丙胺卡因气雾剂在中国健康女性试验参与者单次给药的药代动力学和安全性Ⅰ期研究
[Translation] A Phase I study evaluating the pharmacokinetics and safety of lidocaine-prilocaine aerosol in healthy female participants in China after a single dose.
CTR20260624
评价利多卡因丙胺卡因气雾剂在中国健康男性试验参与者单次给药的药代动力学和安全性Ⅰ期研究
[Translation] A Phase I study evaluating the pharmacokinetics and safety of lidocaine-prilocaine aerosol in healthy male participants in China after a single dose.
CTR20251623
利多卡因丙胺卡因气雾剂治疗成年男性原发性早泄有效性和安全性的随机、双盲、安慰剂及阳性药对照、多中心临床试验
[Translation] A randomized, double-blind, placebo- and active drug-controlled, multicenter clinical trial on the efficacy and safety of lidocaine prilocaine aerosol in the treatment of primary premature ejaculation in adult men
100 Clinical Results associated with Yangzhou Sanyao Pharmaceutical Co. Ltd.
Login to view more data
Login to view more data
100 Deals associated with Yangzhou Sanyao Pharmaceutical Co. Ltd.
Login to view more data
100 Translational Medicine associated with Yangzhou Sanyao Pharmaceutical Co. Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 10 May 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Application
1
1
Phase 1
Approved
2
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free